Former Novartis executive Tsai to lead UK heart drug startup
Bio Pharma Dive
SEPTEMBER 27, 2023
John Tsai, previously Novartis’ chief medical officer, has been named CEO of Forcefield Therapeutics, an 18-month-old biotech working on a treatment for heart attacks.
Let's personalize your content